Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / CA - Why Johnson & Johnson Is Eyeing Protagonist Therapeutics: The Rationale

CA - Why Johnson & Johnson Is Eyeing Protagonist Therapeutics: The Rationale

Xtrackers California Municipal Bonds ETF

2025-10-13 10:09:05 ET

Thesis

It's been a busy week for Protagonist Therapeutics, Inc. (PGTX) in terms of news. They're a name that wouldn't have been on everyone's map before the interest shown by Johnson & Johnson ( JNJ ) ("J&J"); however, after last week, their stock has seen significant upside. Shares are now trading in the $80 range and have seen a 30% jump as a result of the news....

For further details see:

Why Johnson & Johnson Is Eyeing Protagonist Therapeutics: The Rationale

Stock Information
Company Name: Xtrackers California Municipal Bonds ETF
Stock Symbol: CA
Market: NASDAQ
Menu
Get CA Alerts

News, Short Squeeze, Breakout and More Instantly...